Pulmonary Hypertension After Pediatric Allogeneic Hematopoietic Stem Cell Transplant: Incidence, Risk Factors, and Outcomes
Study #: LE19-01d
Study Status: Published
Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: Incidence, risk factors, and outcomes.
Smith MA, Cheng G, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton BK, Peterson A, Savani B, Schoemans H, Schoettler ML, Sorror M, Keller RL, Higham CS, Dvorak CC, Fineman JR, Zinter MS.
Frontiers in Oncology. 2024, May 29: 14(): 14:1415984. doi: 10.3389/fonc.2024.1415984. Epub 2024, May 29. PMCID:PMC11167102.
PMID: 38868534
Abstract